Related Experiment Video
Updated: Jul 8, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Recommended newborn screening policy change for the NICU infant
1Johns Hopkins University, USA.
Insights
Newborn screening (NBS) is vital for early detection of life-threatening infant conditions. Current NBS guidelines in neonatal intensive care units (NICUs) require updates to prevent inaccurate results due to medical interventions.
Area of Science:
- Medical Science
- Public Health
- Neonatology
Background:
- Newborn screening (NBS) is a critical public health strategy for early detection of genetic and metabolic disorders in infants.
- Many screened conditions are life-threatening if not promptly diagnosed and treated within the first two weeks of life.
- Early intervention, including dietary and hormonal therapies, can prevent severe outcomes like neurological damage or death.
Purpose of the Study:
- To evaluate the effectiveness of current NBS guidelines in neonatal intensive care units (NICUs).
- To identify factors that may lead to inaccurate NBS results in the NICU setting.
- To propose necessary revisions to NBS guidelines for NICU patients.
Main Methods:
- Review of existing NBS protocols in NICUs.
- Analysis of potential confounding factors affecting NBS accuracy, such as aminoglycosides, blood transfusions, and heparinized solutions.
- Examination of historical cases leading to guideline development.
Main Results:
- Established NBS guidelines may yield inaccurate results in NICU settings due to various medical interventions.
- Specific interventions like aminoglycosides, blood transfusions, and heparinized solutions can interfere with screening.
- Current guidelines, including early screening and repeat testing, may not adequately account for NICU patient care.
Conclusions:
- NBS guidelines in NICUs need revision to ensure accurate screening results.
- Adjusted guidelines should consider the impact of medical interventions common in NICU care.
- Updated protocols are essential for reliable diagnosis and timely treatment of newborns in critical care settings.
Abstract:
Newborn screening (NBS), the practice by which infants are tested for certain genetic and metabolic conditions by heel prick 3 to 5 days after birth, has been a beneficial and cost-effective public health strategy. Many of the screened conditions present in the first 2 weeks of life and are life threatening. Because of the risk of metabolic acidosis, seizures, coma, neurological devastation, or death, NBS is essential for prompt diagnosis and treatment, including dietary, hormonal, and other interventions. However, due to the fact that aminoglycosides, blood transfusions, nothing by mouth status, and the presence of heparinized solutions all potentially affect the screening results, NBS guidelines in neonatal intensive care units (NICUs) ought to be changed to obviate inaccurate results. These guidelines, originally initiated by nurses at the Johns Hopkins NICU due to the missed diagnosis and death of an infant, include screening the day of birth prior to any interventions, performing the screen at 1 and/or 2 weeks of life, and repeating screening as needed.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:29Drug Dosing: Infants and Children